OTTMUSG00000011289 Inhibitors
Interferon zeta-like precursor, a protein encoded by the Gm13288 gene, is a key player in the innate immune response, particularly involved in antiviral defense and immune regulation. Its functional inhibition can be achieved through various chemical inhibitors, each targeting distinct cellular pathways and mechanisms. One such inhibitor, Etoposide, acts as a potent topoisomerase II inhibitor, disrupting crucial processes in DNA replication and repair. By interfering with these processes, Etoposide indirectly suppresses the functional activity of interferon zeta-like precursor, particularly in the context of DNA damage responses, where the protein's activity is pivotal for coordinating immune defenses against genotoxic stressors.
Additionally, inhibitors like AG-490 play a significant role in inhibiting interferon zeta-like precursor by targeting the JAK-STAT pathway, a central signaling cascade in interferon regulation. AG-490 selectively inhibits JAK2, a kinase critical for STAT protein phosphorylation and activation. This inhibition results in the disruption of downstream signaling events linked to interferon zeta-like precursor, leading to its functional inhibition. These examples illustrate the intricate network of cellular pathways and signaling molecules that govern the activity of interferon zeta-like precursor and highlight how precise chemical inhibitors can effectively modulate its function, thereby contributing to a better understanding of the intricate immune response mechanisms.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Etoposide is a topoisomerase II inhibitor that functions by disrupting DNA replication and repair processes. This interference leads to the functional inhibition of interferon zeta-like precursor, particularly in the context of DNA damage responses, where its activity is crucial. | ||||||
Tyrphostin B42 | 133550-30-8 | sc-3556 | 5 mg | $26.00 | 4 | |
Tyrphostin B42 is a selective inhibitor of JAK2, an essential kinase in the JAK-STAT pathway that mediates interferon signaling. By targeting JAK2, it disrupts the phosphorylation and activation of STAT proteins, leading to the inhibition of interferon zeta-like precursor's downstream signaling and functional activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a phosphoinositide 3-kinase (PI3K) inhibitor, and PI3K/AKT signaling is linked to interferon responses. Inhibiting PI3K with Wortmannin can indirectly suppress interferon zeta-like precursor's activity by interfering with downstream signaling cascades, resulting in functional inhibition. | ||||||
Cidofovir | 113852-37-2 | sc-482141 | 50 mg | $135.00 | ||
Cidofovir is an antiviral agent that inhibits viral DNA polymerases. It can indirectly inhibit interferon zeta-like precursor by preventing viral replication, a process that triggers interferon responses. Cidofovir's action indirectly reduces the functional activity of the protein in antiviral defense mechanisms. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a specific p38 MAP kinase inhibitor, and p38 MAPK signaling is involved in interferon regulation. By inhibiting p38 MAP kinase, it indirectly hampers the phosphorylation events that activate interferon zeta-like precursor, leading to its functional inhibition within the pathway. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib is a proteasome inhibitor that can disrupt the degradation of signaling molecules involved in interferon pathways. By inhibiting proteasomes, it indirectly inhibits interferon zeta-like precursor's degradation, leading to the accumulation of inactive protein and functional inhibition. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor that can disrupt mTOR signaling pathways linked to interferon production. By inhibiting mTOR, it indirectly suppresses the translation and production of interferon zeta-like precursor, thereby functionally inhibiting its role in immune responses. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3-kinase inhibitor that can disrupt PI3K/AKT signaling, which intersects with interferon pathways. By blocking PI3K, it indirectly inhibits the activation of interferon zeta-like precursor and its downstream effects, leading to functional inhibition of the protein's role in immune responses. | ||||||
Fludarabine | 21679-14-1 | sc-204755 sc-204755A | 5 mg 25 mg | $58.00 $204.00 | 15 | |
Fludarabine is a nucleoside analogue that inhibits DNA synthesis. It can indirectly inhibit interferon zeta-like precursor by disrupting cell division and DNA replication, which are essential processes for interferon production and function in immune responses. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin has anti-inflammatory properties and can inhibit NF-κB signaling, a pathway involved in interferon regulation. By blocking NF-κB activation, it indirectly inhibits interferon zeta-like precursor's expression and activity, particularly in inflammatory contexts. | ||||||